Restoring Sleep in Major Depression: Orexin, Melatonin, and More
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
2d ago
In this episode, we explore the latest pharmacologic interventions for managing insomnia in patients with major depressive disorder. Can dual orexin receptor antagonists, melatonin agonists, and low-dose doxepin provide relief for those struggling with sleep? Join us as we discuss the advances in treating insomnia and depression. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CMEs: Navigating Insomnia in Major Depressive Disorder: Advances in Management Other Pharmacologic Interventions for Insomnia ..read more
Visit website
Enhancing Pediatric Depression Treatment: The Role of Fish Oil and CBT
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1w ago
In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 Is Fish Oil Effective in Youth Depression ..read more
Visit website
Pharmacological Strategies for Insomnia in MDD
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1w ago
In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Pharmacologic Interventions for Insomnia: Benzodiazepines and Non-Benzodiazepine Hypnotics ..read more
Visit website
Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
2w ago
In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring. Faculty: Sydney LeFay, D.O. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 56 Antipsychotic Safety in Liver Disease ..read more
Visit website
Insomnia and Depression: A Tangled Web
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
3w ago
In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Understanding the Relationship Between Insomnia Disorder and MDD ..read more
Visit website
ADHD Treatment During Pregnancy: Insights from Denmark
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
3w ago
In this episode, we explore the long-term effects of ADHD medication use during pregnancy on children's development. Can continuing treatment pose risks, or is it safer than previously thought? Join us as we dive into a groundbreaking Danish study that sheds light on this critical question. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes ..read more
Visit website
The Power of Nonpharmacologic Therapies in Fibromyalgia
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we explore the growing evidence for nonpharmacologic therapies in managing fibromyalgia symptoms. Could a combination of exercise, cognitive–behavioral therapy, and integrative approaches, like acupuncture or yoga, be the key to better outcomes for patients resistant to traditional treatments? Faculty: Daniel Clauw, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia Nonpharmacologic Therapies for Fibromyalgia ..read more
Visit website
Highlights From APA 2024: Key Insights on Psychopharmacology
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders. Hosts: Flavio Guzman, M ..read more
Visit website
Antidepressants in Pregnancy: Weighing the Evidence
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we discuss a new study on maternal depression, antidepressant use, and pregnancy complications. Can antidepressants during pregnancy harm the baby? Dr. Lauren Osborne helps us weigh the risks and benefits. Faculty: Lauren Osborne, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 56 Neonatal and Pregnancy Complications Following Maternal Depression or Antidepressant Exposure ..read more
Visit website
Unraveling the Pharmacological Puzzle of Fibromyalgia
Psychopharmacology and Psychiatry Updates
by Psychopharmacology Institute
1M ago
In this episode, we explore the most effective pharmacologic treatments for fibromyalgia, a complex nociplastic pain syndrome. Dr. Daniel Clauw shares his insights on the top drug classes for managing fibromyalgia and discusses why opioids should be avoided. Could the hyperactive endogenous opioid system in fibromyalgia patients explain the ineffectiveness of opioids? Faculty: Daniel Claw, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia Pharmacologic Therapies for Fibromyalgia ..read more
Visit website

Follow Psychopharmacology and Psychiatry Updates on FeedSpot

Continue with Google
Continue with Apple
OR